No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
SMMT241220C17500
- 1.18
- -0.62-34.44%
15min DelayClose Dec 20 16:00 ET
1.18High0.70Low
0.85Open1.80Pre Close61 Volume63 Open Interest17.50Strike Price4.33KTurnover0.00%IV4.53%PremiumDec 20, 2024Expiry Date0.37Intrinsic Value100Multiplier-1DDays to Expiry0.81Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma15.14Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Why Did Summit Therapeutics Inc. (SMMT) Jump Yesterday?
Where Will Summit Therapeutics Be in 5 Years?
Summit Therapeutics Shares Are Trading Higher. The Stock May Be Moving in Sympathy With Neurocrine Biosciences Which Received FDA Approval for CRESNESSITY.
Watching Summit Therapeutics; Traders Circulate Newsletter Mention
How Is The Market Feeling About Summit Therapeutics?
Summit Therapeutics Initiated at Overweight by Wells Fargo